NOXOPHARM-LIMITED
Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced that Veyonda has been approved to move into the second and final stage of the NOXCOVID-1 clinical trial on the advice of the study’s clinicians.
Part 1 of the NOXCOVID-1 trial involved 26 patients and was a dose-escalation arm testing the safety of increasing (400, 600, 800, 1200, 1800 mg) daily Veyonda dosages. The 1800 mg dose was deemed to be sufficiently well tolerated in patients with moderate COVID-19 disease to become the preferred dose. The high tolerance of the drug by patients with very poor lung function provides further evidence of the safety of Veyonda in patients with acute illness.
Noxopharm CEO Dr. Graham Kelly said, “The high potency of Veyonda in blocking cytokine release from damaged tissue in the laboratory meant we were obliged to adopt a very cautious and methodical approach when being used for the first time in patients with poor lung function. We can now be confident that Veyonda, despite its potency, is well tolerated at a dosage we believe will be therapeutic.”
Part 2 of the NOXCOVID-1 trial now is starting to recruit a minimum of 10 and up to 15 patients with moderate-to-severe lung dysfunction. Patients will be treated for up to 14 days with an 1800 mg Veyonda dose each day.
Noxopharm is committed to pursuing its NOXCOVID program for two main reasons: Despite the advent of COVID-19 vaccines, emerging news of new mutant strains of the virus points to a likely ongoing long-term need for effective treatments for COVID-19 patients who go on to develop long-term lung damage and are at high risk of septic shock.
The current pandemic represents a small proportion of patients who die each year from septic shock. Even once the pandemic abates, the need for an effective and safe ongoing treatment for septic shock will remain.
About Noxopharm
Noxopharm is a clinical-stage Australian oncology drug development company with offices in Sydney and New York. The company has a primary focus on the development of Veyonda and is the major shareholder in the nononcology drug development company, Nyrada Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210318005035/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yokogawa to DeliverIntegrated Control Systems for Urban Infrastructure in Green Riyadh Project30.10.2025 02:00:00 CET | Press release
- Contributing to a national urban afforestation initiative that aims to transform the Saudi capital into one of the world's most livable cities - Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary, Yokogawa Saudi Arabia, has been awarded a contract by the Royal Commission for Riyadh City to provide the necessary systems and services for the main command and control center of the Green Riyadh project*. Led by the Government of Saudi Arabia, this national initiative is a key element of Saudi Vision 2030. Its objective is to transform Riyadh into one of the world’s most livable cities through urban greening, enabling residents to lead healthier and more sustainable lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029727530/en/ Riyadh, Saudi Arabia The project will plant 7.5 million trees across parks, public facilities, healthcare centers, and roads by 2030, increasing green space per capita from
R2 Joins Ant International to Expand Credit Access for SMEs in LATAM30.10.2025 01:04:00 CET | Press release
The investment will enable both companies to integrate their expertise to improve credit access for small and medium-sized enterprises (SMEs) in a region facing a credit gap of over US$1 trillion Ant International, a leading global digital payment, digitisation, and financial technology provider, today announced a strategic investment in R2, the leading embedded lending infrastructure company in Latin America (LATAM), to expand access to credit for SMEs across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029918704/en/ From left to right: Roger Larach, Co-Founder and Chief Executive Officer, R2 | Quan Yu, General Manager of Global Credit Services, Ant International | Roger Teran, Co-Founder and Chief Data Officer, R2 R2 enables digital platforms to offer financing solutions quickly and securely through an API-based, end-to-end white-labeled experience. This allows merchants to easily access capital through th
Axelspace Signs MoUs with Two African Organizations to Address Social Challenges through the Utilization of Satellite Data29.10.2025 21:57:00 CET | Press release
Collaborating with Partners in Ghana and Kenya to Develop and Implement Tailored Solutions Axelspace Corporation (“Axelspace”), which develops and operates microsatellites and conducts business to promote a society where space is accessible to people around the world, is pleased to announce the memorandum of understandings (MoUs) with two governmental organizations of African countries on cooperation for addressing social challenges through the utilization of satellite-based Earth observation (EO) data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029793600/en/ Genevieve Edna Apaloo, Ambassador Extraordinary and Plenipotentiary of the Republic of Ghana to Japan and Yuya Nakamura, President and CEO, Axelspace at the signing ceremony on stage at NIHONBASHI SPACE WEEK 2025 Axelspace signed MoUs individually with the Ghana Space Science and Technology Institute (GSSTI) of the Republic of Ghana, and the Regional Centre for M
Celebrating Destination Excellence: TOURISE Unveils Finalists for the 2025 TOURISE Awards29.10.2025 20:58:00 CET | Press release
Anticipation is building as TOURISE today unveils the finalists for the highly anticipated 2025 TOURISE Awards, set to recognize those leading global destinations who are rewriting the very definition of exploration. Twelve destinations have been named as finalists in this year’s TOURISE Awards, setting the pace for the future of tourism. Together they represent places from across the world that are not just changing the game of destination excellence, they are setting entirely new rules to cater to the demands of the modern traveler. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029909575/en/ Selected from a wide array of nominations submitted by passionate globetrotters travelers, industry experts, and organizations across the world, this year’s finalists celebrate places that deliver soul-stirring culture, boundary-pushing experiences, and above all, meaningful and lasting memories. His Excellency Ahmed Al-Khateeb, Mi
Xsolla Enables U.S. Google Play Game Developers to Add External Purchase Links Inside Their Games29.10.2025 20:00:00 CET | Press release
Mobile Game Developers In The United States Can Now Use External Purchase Links In Google Play Titles Following Google’s Latest Policy Update Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced that it can now power external purchases for Android developers following Google’s policy updates in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029226256/en/ (Graphic: Xsolla) Beginning October 29, 2025, U.S. developers can legally include external purchase links in their Google Play games, ending longstanding exclusivity and paving the way for more flexible, direct-to-consumer monetization strategies. With this industry-defining change, Xsolla’s Buy Button and Web Shop solutions provide immediate, compliant pathways for developers to diversify their mobile commerce, maintain player relationships, and optimize revenue. For more than a deca
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom